These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 16101408)

  • 1. FXR, a therapeutic target for bile acid and lipid disorders.
    Westin S; Heyman RA; Martin R
    Mini Rev Med Chem; 2005 Aug; 5(8):719-27. PubMed ID: 16101408
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of the enterohepatic circulation of bile salts and nuclear hormone receptors in the regulation of cholesterol homeostasis: Bile salts as ligands for nuclear hormone receptors.
    Redinger RN
    Can J Gastroenterol; 2003 Apr; 17(4):265-71. PubMed ID: 12704471
    [TBL] [Abstract][Full Text] [Related]  

  • 3. FXR, a target for different diseases.
    Wang YD; Chen WD; Huang W
    Histol Histopathol; 2008 May; 23(5):621-7. PubMed ID: 18283647
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bile acids induce the expression of the human peroxisome proliferator-activated receptor alpha gene via activation of the farnesoid X receptor.
    Pineda Torra I; Claudel T; Duval C; Kosykh V; Fruchart JC; Staels B
    Mol Endocrinol; 2003 Feb; 17(2):259-72. PubMed ID: 12554753
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting farnesoid X receptor for liver and metabolic disorders.
    Fiorucci S; Rizzo G; Donini A; Distrutti E; Santucci L
    Trends Mol Med; 2007 Jul; 13(7):298-309. PubMed ID: 17588816
    [TBL] [Abstract][Full Text] [Related]  

  • 6. FXR: a promising target for the metabolic syndrome?
    Cariou B; Staels B
    Trends Pharmacol Sci; 2007 May; 28(5):236-43. PubMed ID: 17412431
    [TBL] [Abstract][Full Text] [Related]  

  • 7. FXR, a bile acid receptor and biological sensor.
    Tu H; Okamoto AY; Shan B
    Trends Cardiovasc Med; 2000 Jan; 10(1):30-5. PubMed ID: 11150726
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of a bile acid-responsive element in the human ileal bile acid-binding protein gene. Involvement of the farnesoid X receptor/9-cis-retinoic acid receptor heterodimer.
    Grober J; Zaghini I; Fujii H; Jones SA; Kliewer SA; Willson TM; Ono T; Besnard P
    J Biol Chem; 1999 Oct; 274(42):29749-54. PubMed ID: 10514450
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Farnesoid X receptor: a molecular link between bile acid and lipid and glucose metabolism.
    Claudel T; Staels B; Kuipers F
    Arterioscler Thromb Vasc Biol; 2005 Oct; 25(10):2020-30. PubMed ID: 16037564
    [TBL] [Abstract][Full Text] [Related]  

  • 10. BAREing it all: the adoption of LXR and FXR and their roles in lipid homeostasis.
    Edwards PA; Kast HR; Anisfeld AM
    J Lipid Res; 2002 Jan; 43(1):2-12. PubMed ID: 11792716
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of absorption and ABC1-mediated efflux of cholesterol by RXR heterodimers.
    Repa JJ; Turley SD; Lobaccaro JA; Medina J; Li L; Lustig K; Shan B; Heyman RA; Dietschy JM; Mangelsdorf DJ
    Science; 2000 Sep; 289(5484):1524-9. PubMed ID: 10968783
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bile salt excretory pump: biology and pathobiology.
    Suchy FJ; Ananthanarayanan M
    J Pediatr Gastroenterol Nutr; 2006 Jul; 43 Suppl 1():S10-6. PubMed ID: 16819395
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endogenous bile acids are ligands for the nuclear receptor FXR/BAR.
    Wang H; Chen J; Hollister K; Sowers LC; Forman BM
    Mol Cell; 1999 May; 3(5):543-53. PubMed ID: 10360171
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Knockdown of ATP8B1 expression leads to specific downregulation of the bile acid sensor FXR in HepG2 cells: effect of the FXR agonist GW4064.
    Martínez-Fernández P; Hierro L; Jara P; Alvarez L
    Am J Physiol Gastrointest Liver Physiol; 2009 May; 296(5):G1119-29. PubMed ID: 19228886
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discovery and optimization of non-steroidal FXR agonists from natural product-like libraries.
    Nicolaou KC; Evans RM; Roecker AJ; Hughes R; Downes M; Pfefferkorn JA
    Org Biomol Chem; 2003 Mar; 1(6):908-20. PubMed ID: 12929628
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The nuclear receptors FXR and LXRalpha: potential targets for the development of drugs affecting lipid metabolism and neoplastic diseases.
    Niesor EJ; Flach J; Lopes-Antoni I; Perez A; Bentzen CL
    Curr Pharm Des; 2001 Mar; 7(4):231-59. PubMed ID: 11254888
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Discovery of farnesoid X receptor and its role in bile acid metabolism.
    Chiang JYL; Ferrell JM
    Mol Cell Endocrinol; 2022 May; 548():111618. PubMed ID: 35283218
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The cholesterol-raising factor from coffee beans, cafestol, as an agonist ligand for the farnesoid and pregnane X receptors.
    Ricketts ML; Boekschoten MV; Kreeft AJ; Hooiveld GJ; Moen CJ; Müller M; Frants RR; Kasanmoentalib S; Post SM; Princen HM; Porter JG; Katan MB; Hofker MH; Moore DD
    Mol Endocrinol; 2007 Jul; 21(7):1603-16. PubMed ID: 17456796
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of FXR in disorders of bile acid homeostasis.
    Eloranta JJ; Kullak-Ublick GA
    Physiology (Bethesda); 2008 Oct; 23():286-95. PubMed ID: 18927204
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Binding mode of 6ECDCA, a potent bile acid agonist of the farnesoid X receptor (FXR).
    Costantino G; Macchiarulo A; Entrena-Guadix A; Camaioni E; Pellicciari R
    Bioorg Med Chem Lett; 2003 Jun; 13(11):1865-8. PubMed ID: 12749886
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.